Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ProUroCare Medical Inc.v323900_ex99-1.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

FORM 8-K

  

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported) September 18, 2012

 

ProUroCare Medical Inc.
(Exact name of registrant as specified in its charter)

 

Nevada 000-51774 20-1212923
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

  

6440 Flying Cloud Dr., STE 101, Eden Prairie, MN 55416
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code 952-476-9093

  

N/A
(Former name or former address, if changed since last report.)
         

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

 

 

 

 

 
 

 

Item 7.01 Regulation FD Disclosure

 

On September 18, 2010, ProUroCare Medical Inc. posted a shareholder status update presentation on its website www.prourocare.com/update/html. The presentation is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits.

 

99.1September Shareholder Update presentation posted by ProUroCare Medical Inc. on its website on September 18, 2012.

 

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PROUROCARE MEDICAL INC.
     
     
September 18, 2012 By: 

/s/Richard C. Carlson

    Richard C. Carlson 
    Chief Executive Officer